January/February 2026 Insert
One to Watch: Hasenin Al-khersan, MD
Hasenin Al-khersan, MD
January/February 2026 | Surgical Pearls
Implanting Encapsulated Cell-Based Gene Therapy
Add MacTel therapy to your surgical armamentarium.
Thomas M. Aaberg Jr, MD; Charles C. Wykoff, MD, PhD, FASRS, FACS; and Liliya Sutherland, DO
November/December 2025 | Global Perspectives
The Need for Novel Intraocular Tamponade Agents
Surgical, diagnostic, and environmental considerations of standard tamponades reveal the potential benefits of a better solution.
Mario Romano, MD, PhD; Robert L. Avery, MD; David A. Eichenbaum, MD; and Anat Loewenstein, MD
May/June 2025 Supplement
Evolutions in the Understanding and Treatment of Macular Telangiectasia Type 2
Charles C. Wykoff, MD, PhD, and Dean Eliott, MD
May/June 2025 | Special Report
Implantable Drug Delivery: A Look At Pharmacokinetics
Novel approaches are showing promise for addressing treatment burden in retinal disease.
Charles C. Wykoff, MD, PhD, FASRS, FACS
April 2025 | Meeting Minutes
Key Lectures From Angiogenesis 2025
A look at top presentations and discussions ranging from imaging and therapy to the latest clinical trial data.
Catherine Manthorp, BA, Senior Editor; Alex Brodin, MA, Senior Editor; and Rebecca Hepp, MA, Editor-in-Chief
January/February 2025 | Features
Novel Surgical Techniques to Master
An overview of ports, implants, and gene therapy making their way into your surgical toolkit.
David A. Eichenbaum, MD, and Albert J. Augustin, MD
January/February 2025 | Features
Retina OR Potpourri: Five Questions for Five Top Surgeons
Experts discuss tough surgical scenarios and controversial topics.
Steve Charles, MD, FACS, FICS; Charles C. Wykoff, MD, PhD, FASRS, FACS; Audina M. Berrocal, MD; Sengul Ozdek, MD, FEBO; and Edward F. Hall, MD
November/December 2024 | Special Report
Letter to the Editor: Hurdles to AI Adoption in Retina
Deep-learning algorithms have yet to meaningfully affect clinical practice—here’s why.
Hasenin Al-khersan, MD; Eliot Dow, MD, PHD; and Charles C. Wykoff, MD, PhD, FASRS, FACS
November/December 2024 | Imaging
A Closer Look at Ellipsoid Zone Attenuation
Could this structural finding, a newly-approved clinical trial endpoint, help us predict AMD progression? Here’s what we know so far.
Justis P. Ehlers, MD, and Charles C. Wykoff, MD, PhD, FASRS, FACS
May/June 2024 | Meeting Minutes
What’s New at Angiogenesis 2024
Experts from around the world shared the latest data and clinical updates.
Catherine Manthorp, BA, Senior Editor; Alex Brodin, MA, Senior Editor; and Rebecca Hepp, MA, Editor-in-Chief
January/February 2024 | Meeting Minutes
Tackling Diabetes at ARDS 2023
Experts came together in Snowmass Village to discuss the nuances of treating diabetic eye disease.
Mohammad Ali Sadiq, MD
October 2023 | Meeting Minutes
The Panels at ARDS 2023: GA Therapy and OR Tricks
Experts discussed medical innovations, surgical techniques, and what’s changing our clinical practice.
Ethan M. Stern, MD
July/August 2023 Supplement
SYFOVRE® (pegcetacoplan injection): An FDA-Approved Treatment
Roger A. Goldberg, MD, MBA; Rishi Singh MD; and Charles Wykoff, MD, PhD
October 2022 | Meeting Minutes
A Peek at The Clinical Trials at the Summit
The latest research was on display at the 2nd annual CTS meeting at Lake Tahoe, Nevada.
Aamir A. Aziz, MSII
September 2022 | Meeting Minutes
Lifetime Mentorship Award: A VBS Tradition
This year’s lecture by Julia A. Haller, MD, focused on diversity, equity, and inclusion in retina.
Thomas Lazzarini, MD
